Immune Response Testing Market Report 2025

The immune response testing market size has grown rapidly in recent years. It will grow from $14.77 billion in 2024 to $16.36 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth during the historic period can be attributed to an increased focus on vaccine efficacy monitoring, the expanding use of immunotherapy in cancer treatment, rising awareness of immune system health, the expansion of global disease surveillance programs, growing investments in biopharmaceutical research and development, and a higher demand for transplant compatibility testing.

The immune response testing market size is expected to see rapid growth in the next few years. It will grow to $24.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth during the forecast period can be attributed to the increasing incidence of emerging zoonotic diseases, rising demand for at-home immune test kits, greater adoption of preventive healthcare, growing investments in pandemic preparedness, and an expanding need for transplant compatibility testing. Major trends expected in the forecast period include advancements in vaccine efficacy monitoring, enhanced use of AI in immune profiling, innovations in at-home immune test kits, integration of immunotherapy in cancer treatment, and progress in transplant compatibility testing.

The rising prevalence of autoimmune diseases is expected to drive growth in the immune response testing market. Autoimmune diseases occur when the body’s immune system mistakenly attacks healthy cells and tissues. This rise is largely linked to increased exposure to environmental pollutants, which can disrupt immune function and trigger autoimmune reactions. Immune response testing plays a critical role in disease management by providing detailed insights into immune activity, enabling early diagnosis, personalized treatment plans, and more effective monitoring. For example, a survey reported by Versorgungsatlas.de in 2022 found that out of 73,241,305 insured individuals in Germany, 6,304,340 were diagnosed with at least one autoimmune disease, yielding a prevalence rate of 8.61%.

Companies in the immune response testing market are increasingly developing automated assays to improve diagnostic efficiency and accuracy. Automated immune response assays are laboratory tests that measure immune activity, such as antibody levels or cytokine profiles, with minimal manual intervention. In August 2022, F. Hoffmann-La Roche AG launched the Elecsys IGRA SARS-CoV-2 test, an automated interferon-gamma release assay (IGRA) that detects T-cell responses to SARS-CoV-2. This test runs on Roche’s cobas e analyzers, enabling high-throughput testing with rapid results, supporting large-scale immune monitoring, and improving understanding of long-term immunity and vaccine efficacy.

In July 2024, Thermo Fisher Scientific acquired Olink Holding AB for \$3.1 billion to strengthen its capabilities in proteomics and immune response testing. Olink, a Sweden-based biotechnology company, specializes in protein biomarker detection for immune monitoring. This acquisition enhances Thermo Fisher’s precision medicine and research portfolio, enabling faster and more comprehensive immune profiling for better patient outcomes.

Major players in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, Myriad Genetics Inc., NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc.

North America was the largest region in the immune response testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in immune response testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the immune response testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Immune response testing is a diagnostic procedure that assesses how the immune system responds to a specific antigen, pathogen, or vaccine. It measures the presence, type, and intensity of immune activity by detecting antibodies, immune cells, or cytokine levels in the body. This testing is useful for determining immunity status, diagnosing immune-related disorders, and guiding treatment or vaccination strategies.

The primary types of immune response testing include antibody testing, cytokine testing, cellular testing, and complement system testing. Antibody testing involves detecting specific antibodies in the blood, which indicates a previous infection or an immune response to a particular pathogen. These tests are used in allergy diagnostics, human immunodeficiency virus (HIV) management, cancer, rheumatoid arthritis, systemic lupus erythematosus, and other conditions, serving a wide array of end users such as hospitals, clinics, diagnostic laboratories, research institutes, and home care settings.

The immune response testing market research report is one of a series of new reports that provides immune response testing market statistics, including immune response testing industry global market size, regional shares, competitors with an immune response testing market share, detailed immune response testing market segments, market trends and opportunities, and any further data you may need to thrive in the immune response testing industry. This immune response testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immune response testing market includes revenues earned by entities through measuring immune cell activity, antibody detection and quantification, cytokine profiling, T-cell and B-cell functional assays, allergy testing, vaccine efficacy assessment, autoimmune disease testing, infectious disease immune response analysis, and monitoring immune-related therapy effectiveness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.